• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产碳青霉烯酶菌株的长期携带:临床危险因素以及碳青霉烯酶和菌株类型的影响

Prolonged Carriage of Carbapenemase-Producing : Clinical Risk Factors and the Influence of Carbapenemase and Organism Types.

作者信息

Kim Yong Kyun, Chang In Bok, Kim Han Sung, Song Wonkeun, Lee Seung Soon

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Korea.

Department of Neurosurgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Korea.

出版信息

J Clin Med. 2021 Jan 15;10(2):310. doi: 10.3390/jcm10020310.

DOI:10.3390/jcm10020310
PMID:33467637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830152/
Abstract

Prolonged carriage of carbapenemase-producing (CPE) constitutes a substantial epidemiologic threat. This study aimed to evaluate whether the types of carbapenemase and organism can affect the duration of carriage and to evaluate the clinical factors associated with prolonged carriage. We retrospectively reviewed data for patients admitted between May 2013 and August 2018 who were identified as CPE carriers. A total of 702 patients were identified; the major types of carbapenemase and organism were Oxacillinase (OXA)-48-like ( = 480, 68.4%) and () ( = 584, 83.2%). The analyses of time to spontaneous decolonization using the Kaplan-Meier method showed that OXA-48-like and were significantly associated with prolonged carriage (log rank, = 0.001 and < 0.001). In multivariable logistic analysis to assess the risk factors for CPE prolonged carriage in the 188 patients with available follow-up culture data for 3 months, (adjusted odds ratio [aOR] 6.58; 95% confidence interval [CI], 1.05-41.27; = 0.044), CPE positive clinical specimen (aOR 11.14; 95% CI, 4.73-26.25; < 0.001), and concurrent infection (CDI) (aOR 3.98, 95% CI 1.29-12.26; = 0.016) were predictive of prolonged carriage. Our results suggest that CP- may have higher probability of prolonged carriage, while the effect of OXA-48-like CPE is inconclusive. Furthermore, patients with CP- who had positive clinical specimen or concurrent CDI can cause a vicious circle in prolonged carriage.

摘要

携带产碳青霉烯酶(CPE)的时间延长构成了重大的流行病学威胁。本研究旨在评估碳青霉烯酶类型和生物体是否会影响携带持续时间,并评估与携带时间延长相关的临床因素。我们回顾性分析了2013年5月至2018年8月期间入院的被确定为CPE携带者的患者数据。共确定了702例患者;碳青霉烯酶和生物体的主要类型为奥沙西林酶(OXA)-48样(n = 480,68.4%)和肺炎克雷伯菌(n = 584,83.2%)。使用Kaplan-Meier方法对自发清除时间的分析表明,OXA-48样和肺炎克雷伯菌与携带时间延长显著相关(对数秩检验,P = 0.001和P < 0.001)。在对188例有3个月可用随访培养数据的患者进行的多变量逻辑分析中,以评估CPE携带时间延长的危险因素,肺炎克雷伯菌(调整优势比[aOR] 6.58;95%置信区间[CI],1.05 - 41.27;P = 0.044)、CPE阳性临床标本(aOR 11.14;95% CI,4.73 - 26.25;P < 0.001)和并发艰难梭菌感染(CDI)(aOR 3.98,95% CI 1.29 - 12.26;P = 0.016)可预测携带时间延长。我们的结果表明,肺炎克雷伯菌CPE可能有更高的携带时间延长概率,而OXA-48样CPE的影响尚无定论。此外,临床标本呈阳性或并发CDI的肺炎克雷伯菌CPE患者在携带时间延长方面可导致恶性循环。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/911e585b23d1/jcm-10-00310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/8013851ab290/jcm-10-00310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/c1c93d1a2c4e/jcm-10-00310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/911e585b23d1/jcm-10-00310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/8013851ab290/jcm-10-00310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/c1c93d1a2c4e/jcm-10-00310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e9a/7830152/911e585b23d1/jcm-10-00310-g003.jpg

相似文献

1
Prolonged Carriage of Carbapenemase-Producing : Clinical Risk Factors and the Influence of Carbapenemase and Organism Types.产碳青霉烯酶菌株的长期携带:临床危险因素以及碳青霉烯酶和菌株类型的影响
J Clin Med. 2021 Jan 15;10(2):310. doi: 10.3390/jcm10020310.
2
Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage.临床因素预测已知定植携带产碳青霉烯酶肺炎克雷伯菌碳青霉烯耐药肠杆菌科患者中持续定植的情况。
J Hosp Infect. 2018 Aug;99(4):405-412. doi: 10.1016/j.jhin.2017.10.017. Epub 2017 Oct 27.
3
Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.外科重症监护病房入院时产碳青霉烯酶肠杆菌科细菌定植的危险因素:一项回顾性研究。
Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):333-337. doi: 10.1016/j.eimc.2016.02.017. Epub 2016 Mar 22.
4
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.碳青霉烯类药物暴露前史是产非碳青霉烯酶类碳青霉烯耐药肠杆菌科和产碳青霉烯酶肠杆菌科的危险因素。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00845-19. Print 2019 Oct.
5
Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.韩国五家医院产碳青霉烯酶肠杆菌科细菌的流行情况及分子特征
Ann Lab Med. 2016 Nov;36(6):529-35. doi: 10.3343/alm.2016.36.6.529.
6
Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay.快速鉴定产 OXA-48 样、KPC、NDM 和 VIM 碳青霉烯酶肠杆菌科:RESIST-4 O.K.N.V. 多重侧向流检测的评估。
Ann Lab Med. 2020 May;40(3):259-263. doi: 10.3343/alm.2020.40.3.259.
7
Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.2014-2016 年斯洛文尼亚成功控制首例 OXA-48 和/或 NDM 碳青霉烯酶产生的肺炎克雷伯菌爆发
J Hosp Infect. 2019 Feb;101(2):142-149. doi: 10.1016/j.jhin.2018.10.022. Epub 2018 Nov 3.
8
Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.西班牙马德里一家大学附属医院在 R-GNOSIS 项目中对定植患者中产碳青霉烯酶肠杆菌科的特征描述表明,随着时间的推移,克隆多样性不断增加,同时高风险克隆得以维持。
J Antimicrob Chemother. 2018 Nov 1;73(11):3039-3043. doi: 10.1093/jac/dky284.
9
Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India.印度一家三级医疗中心重症监护病房患者中产碳青霉烯酶肠杆菌科细菌粪便携带的危险因素。
BMC Microbiol. 2016 Jul 8;16(1):138. doi: 10.1186/s12866-016-0763-y.
10
A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.西班牙马德里长期护理医院产碳青霉烯酶肠杆菌科细菌粪便携带者的单日现况研究描绘了其复杂的克隆和多克隆传播情况。
J Antimicrob Chemother. 2016 Feb;71(2):348-52. doi: 10.1093/jac/dkv355. Epub 2015 Oct 30.

引用本文的文献

1
Carbapenem-resistant Enterobacterales infection and colonization in patients with severe burns: a retrospective cohort study in a single burn center.严重烧伤患者中耐碳青霉烯类肠杆菌科细菌感染与定植:一项在单一烧伤中心开展的回顾性队列研究
Antimicrob Resist Infect Control. 2025 Jan 29;14(1):3. doi: 10.1186/s13756-025-01514-9.
2
Evaluation of the BD Phoenix CPO Detect Panel for Detection and Classification of Carbapenemase Producing .BD Phoenix CPO检测板用于产碳青霉烯酶检测和分类的评估
Antibiotics (Basel). 2023 Jul 21;12(7):1215. doi: 10.3390/antibiotics12071215.
3
Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization.

本文引用的文献

1
The Rate of Acquisition of Carbapenemase-Producing among Close Contact Patients Depending on Carbapenemase Enzymes.根据碳青霉烯酶种类,密切接触患者中碳青霉烯酶产生菌的获得率
Infect Chemother. 2020 Mar;52(1):39-47. doi: 10.3947/ic.2020.52.1.39. Epub 2020 Feb 20.
2
Current infection prevention and antibiotic stewardship program practices: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN).当前感染预防和抗生素管理计划实践:美国医疗保健流行病学学会(SHEA)研究网络(SRN)的调查。
Infect Control Hosp Epidemiol. 2019 Sep;40(9):1046-1049. doi: 10.1017/ice.2019.172. Epub 2019 Jul 17.
3
定植史住院患者发生耐碳青霉烯肠杆菌属感染的危险因素
J Clin Lab Anal. 2022 Nov;36(11):e24715. doi: 10.1002/jcla.24715. Epub 2022 Sep 30.
4
Occurrence and Characteristics of Carbapenem-Resistant Strains Isolated from Hospitalized Patients in Poland-A Single Centre Study.波兰一家单中心研究:从住院患者中分离出的耐碳青霉烯类菌株的发生情况及特征
Pathogens. 2022 Jul 29;11(8):859. doi: 10.3390/pathogens11080859.
The effect of gut microbiota and probiotic organisms on the properties of extended spectrum beta-lactamase producing and carbapenem resistant Enterobacteriaceae including growth, beta-lactamase activity and gene transmissibility.
肠道微生物群和益生菌对产超广谱β-内酰胺酶和耐碳青霉烯类肠杆菌科的特性的影响,包括生长、β-内酰胺酶活性和基因可传递性。
J Infect Chemother. 2019 Nov;25(11):894-900. doi: 10.1016/j.jiac.2019.04.021. Epub 2019 Jun 6.
4
The Likelihood of Developing a Carbapenem-Resistant Infection during a Hospital Stay.住院期间发生碳青霉烯类耐药感染的可能性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00757-19. Print 2019 Aug.
5
Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis.碳青霉烯类耐药肠杆菌科与死亡的关联:系统评价和荟萃分析。
Am J Infect Control. 2019 Oct;47(10):1200-1212. doi: 10.1016/j.ajic.2019.03.020. Epub 2019 May 7.
6
Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon.在模拟人类结肠的体外肠道模型中传播多种碳青霉烯类耐药基因。
J Antimicrob Chemother. 2019 Jul 1;74(7):1876-1883. doi: 10.1093/jac/dkz106.
7
Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review.粪便微生物群移植根除多重耐药菌定植:系统评价。
Clin Microbiol Infect. 2019 Aug;25(8):958-963. doi: 10.1016/j.cmi.2019.04.006. Epub 2019 Apr 12.
8
Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis.粪便微生物群移植在肠道去定植抗生素耐药菌中的应用:系统评价和荟萃分析。
J Hosp Infect. 2019 Jun;102(2):174-188. doi: 10.1016/j.jhin.2019.03.010. Epub 2019 Mar 26.
9
Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.预测肠外定植碳青霉烯类耐药肠杆菌科(CRE)和其他碳青霉烯类耐药菌(CRO)的概率。
Infect Control Hosp Epidemiol. 2019 May;40(5):541-550. doi: 10.1017/ice.2019.42. Epub 2019 Mar 27.
10
Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital.耐碳青霉烯类肠杆菌科细菌的流行病学:一家三级医院的5年经验
Infect Drug Resist. 2019 Feb 20;12:461-468. doi: 10.2147/IDR.S192540. eCollection 2019.